-transparent.png){kind=logo}
Nonthrombocytopenic purpura developed in a patient receiving hexamethylene bisacetamide, a tumor-differentiating agent in vitro that is in phase I clinical trials. Histopathological examination revealed features of leukocytoclastic vasculitis with deposition of IgA and complement in the dermal vasculature. Leukocytoclastic vasculitis, an extremely rare complication of therapy with antineoplastic agents, is reported to alert others using this compound of this association.
Related Publications
E K Rowinsky, and
W P McGuire, and
G J Anhalt, and
D S Ettinger, and
R C Donehower
January 1987,
Progress in clinical and biological research,
E K Rowinsky, and
W P McGuire, and
G J Anhalt, and
D S Ettinger, and
R C Donehower
February 1982,
Cancer research,
E K Rowinsky, and
W P McGuire, and
G J Anhalt, and
D S Ettinger, and
R C Donehower
January 1992,
Cancer chemotherapy and pharmacology,
E K Rowinsky, and
W P McGuire, and
G J Anhalt, and
D S Ettinger, and
R C Donehower
October 2008,
Zhongguo shi yan xue ye xue za zhi,
E K Rowinsky, and
W P McGuire, and
G J Anhalt, and
D S Ettinger, and
R C Donehower
September 2001,
Kidney international,
E K Rowinsky, and
W P McGuire, and
G J Anhalt, and
D S Ettinger, and
R C Donehower
March 1987,
Journal of chromatography,
E K Rowinsky, and
W P McGuire, and
G J Anhalt, and
D S Ettinger, and
R C Donehower
April 2004,
World journal of gastroenterology,
E K Rowinsky, and
W P McGuire, and
G J Anhalt, and
D S Ettinger, and
R C Donehower
February 2007,
Experimental hematology,
E K Rowinsky, and
W P McGuire, and
G J Anhalt, and
D S Ettinger, and
R C Donehower
March 1986,
Cancer research,
E K Rowinsky, and
W P McGuire, and
G J Anhalt, and
D S Ettinger, and
R C Donehower
November 1992,
The Journal of biological chemistry,
